DuPont Pharmaceuticals Co.

A $44.5 million settlement has been reached in the class action lawsuit filed on behalf of consumers who purchased the blood-thinning medication, Coumadin. The suit alleged that the company disseminated false and misleading information about generic versions of Coumadin. (Dec-10-04) [THE DAILY ITEM]

Legal Help

If you have a similar problem and would like to be contacted by a lawyer at no obligation, please click here to fill in our form to submit your complaint.

Add Your Comment on This Issue

Fields marked * are mandatory. Please read our comment guidelines before posting.


Note: Your name will be published with your comment.

*Email Address:

Your email will only be used if a response is needed.

*Your Comment: